Home > Insider Trading > Filing (0001104659-22-032997)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1124524	Cryoport Inc.	CYRX	Pharmaceutical Preparations (2834)	880313393

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1848218	W Mark Sawicki	C/O Cryoport Inc. 112 Westwood Place, Suite 350 Brentwood TN 37027	Chief Scientific Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-03-09	2,667	$0.00	52,796	No	4	M	Direct
Common Stock	Disposition	2022-03-09	1,410	$31.05	51,386	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Rights	Disposition	2022-03-09	2,667	$0.00	2,667	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
8,000			No	4	M	Direct

Footnotes

Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock.
Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.
The originally granted restricted stock rights vest in four equal annual installments beginning 3/9/2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2022.